, 1998 and Vertzoni et al , 2005)

, 1998 and Vertzoni et al., 2005). Capmatinib research buy Ethanol can act as a cosolvent and increase the Sapp in gastrointestinal fluids. This may therefore affect the absorption of poorly soluble drugs. Common modified release formulations carrying high doses of drugs have been shown to disintegrate prematurely and unload the complete dose in the small intestine

in response to ethanol intake ( Fadda et al., 2008 and Walden et al., 2007). This phenomenon is referred to as dose dumping and can lead to increased and potentially hazardous plasma concentrations and adverse side effects of drugs with narrow therapeutic window ( Lennernäs, 2009). A well-known example of this phenomenon is hydromorphone for which one formulation was withdrawn from the market in 2005 after reports of ethanol-induced, dose-dumping-related, adverse drug reactions (ADR). The withdrawn product was a capsule with an extended release formulation consisting of hotmelt extruded granules of the drug, ammonio methacrylate copolymer type b and ethylcellulose. The latter GSK1349572 has been shown to be

sensitive to ethanol in dissolution tests ( Fadda et al., 2008). Following this observation the FDA composed a number of substance specific guidelines (e.g., bupropion hydrochloride, morphine sulfate and trospium chloride) to test for ethanol sensitivity of modified release formulations. In these guidelines dissolution behavior should be assessed for 2 h with 0%, 5%, 20% and 40% v/v ethanol in an acidic medium reflecting the gastric milieu ( Anand et al., 2011). We hypothesized that immediate release formulations of drugs with low solubility in gastrointestinal fluids may, in a similar fashion as extended release formulations during dose-dumping,

show increased absorption in response to alcohol intake. This hypothesis is based on the large drug load of such compounds which is not dissolved during gastrointestinal transit under normal fasted conditions. If the presence of ethanol in gastrointestinal fluids increases the dissolution rate and/or the Sapp of a compound, it may also affect the absorption Linifanib (ABT-869) profile of that drug ( Fig. 1). Indeed, in a previous study investigating 22 compounds in FaSSIF, we found that non-ionizable compounds and weak acids in particular were at a high risk for obtaining significantly different dissolution profiles when administered with ethanol. However, ethanol is rapidly absorbed in the intestinal tract and the impact on absorption was not revealed in the previous study. For instance, it has been shown that if ethanol is co-administered with water, the ethanol disappears from the gastric compartment within 30 min and half of the dose is emptied into the duodenum within 5 min ( Levitt et al., 1997).

CD11c is also known as integrin αX and interacts

with its

CD11c is also known as integrin αX and interacts

with its complement integrin b2 (also called CD18). CD11c is widely employed as a marker of murine DCs. Thirty minutes later, the DCs were gently washed with 0.01 M PBS, resuspended GSK1349572 ic50 at 5 × 106 cells/ml in PBS and detected by flow cytometry. In the control groups, LPS was added into the culture at 2 μg/ml as a positive control. rTs-PmyN was used as an irrelevant protein control, and PBS was added as a blank control. To exclude the effects of possible contamination of the recombinant proteins by LPS, the inhibitor polymyxin B was added at 30 μg/ml as a control in all tested groups. Mouse CD4+ T cells were isolated from the spleens of BALB/c mice infected with 500 T. spiralis ML for 45 days using anti-CD4 buy Epacadostat magnetic beads (Miltenyi Biotec, Germany) following the manufacturer’s instructions. The isolated cells contained 94% CD4+ cells as determined by FACS analysis. The isolated CD4+

T cells were resuspended at 5 × 105 ml−1 and co-incubated with 1 × 105 ml−1 DCs stimulated with rTs-Hsp70 or other controls as mentioned above and pretreated with mitomycin C. The co-incubation was continued for 48 h at 37 °C, and the cells were then harvested, washed, resuspended in fresh medium and seeded into 96-well flat-bottom cell culture plates. Next, 25 μl 5 mg/ml MTS was added to each well, and incubation was continued for 4 h. The proliferation was measured using the MTS kit (Promega, USA), and the stimulation index was calculated according to the manufacturer’s protocol. To measure the cytokines secreted by the CD4+ T cells that were co-incubated with the stimulated DCs, 2 × 105 CD4+ T cells were co-incubated with rTs-Hsp70-stimulated DCs at a ratio of 5:1 in 96-well ELISPOT plates for 48 h at 37 °C. ELISPOT assays for detecting the CD4+ T cell-expressed IFN-γ, IL-2, IL-4 and IL-6 were performed as

previously described [24]. After being incubated with 10 μg/ml rTs-Hsp70 for 48 h, the mouse bone marrow-derived DCs were washed twice in RPMI 1640 to remove the about excess FBS and stimulator and then resuspended in PBS. Each female naïve BALB/c mouse in a group of 30 mice was injected intraperitoneally with 5 × 105 rTs-Hsp70-stimulated DCs. The DCs treated with LPS, rTs-PmyN and PBS were used as controls. All mice were transferred two more times with the same number of treated DCs at an interval of 2 weeks. The sera were collected through tail bleeding of the mice one week after each DC transfer and then every two weeks after last DC transfer until the 11th week (i.e., 0, 1, 3, 5, 7, 9, and 11 weeks). Anti-rTs-Hsp70 total IgG, IgG1, and IgG2a in the collected sera were detected by an indirect ELISA as described previously [25].

2 Intrascrotal tuberculomas are very rare, with very few cases re

2 Intrascrotal tuberculomas are very rare, with very few cases reported in the English literature. Tuberculosis of the spermatic cord is usually a disease that affects the sexually active man with a genitourinary contamination. But the few cases described in childhood imply the possibility of hematogenous spread of the bacillus. It can also affect patients with pulmonary infection

(<1%).3 Contamination by bacille Calmette-Guérin instillation for bladder cancer has also been described but is uncommon. Prostate is more usually involved4 Clinically, the patients show a painful unilateral I-BET151 concentration swelling of the scrotum. Voiding problems are usually absent when only the extraurinary organs are involved. As in our case, usual tuberculous signs such as fever, night sweats, and weight loss can be absent. Imaging findings including ultrasonography and computed tomographic scan are not specific. Search for bacillus in urine and semen should be performed in case of call signs

(hematuria, hemospermia, dysuria, and so forth). Polymerase chain reaction is very useful in this indication and gives quick detection. Differential diagnosis is represented by benign and malignant conditions. Scrotal tuberculoma is usually a peroperative discovery. Selleckchem Venetoclax Most patients are operated for genital suspect masses, and unfortunately, most of them undergo undue orchiectomy (75%).5 This kind of mistake can be avoided by a thorough preoperative checkup (clinical examination, tuberculosis skin test, ultrasonography, chest radiography, and urine and semen analyses) and a peroperative frozen section. Limited resection of the mass with preservation of the testes and epididymis must be performed once malignancy is excluded. The medical treatment consists in the combination Casein kinase 1 of powerful antituberculous drugs according to the regimen: 2 (rifampicin + isoniazid + pyrazinamide + ethambutol) + 4 (rifampicin

+ isoniazid) (R, rifampicin 10 mg/kg/J; H, isoniazid 5 mg/kg/J; Z, pyrazinamid 20-30 mg/kg/J). Though it is only 1 case, the tuberculosis of the spermatic cord is a rare condition that must be kept in mind, especially in developed countries where tuberculosis has known recrudescence in the last decades. A complete preoperative checkup with a peroperative frozen section (when available) must be performed to avoid an excessive surgery that can threaten the patient’s fertility. The authors declare that they have no relevant conflicts of interest. “
“A 45-year-old male patient presented to our institute with a history of left hip pain for 6 months and no past medical history of chronic diseases. No history of trauma is provided. The patient also went to a private clinic with the same complain and diagnosed to have osteoarthritis of the left hip joint and treated using nonsteroidal anti-inflammatory drugs.

Soil degradation, including decreased fertility and increased ero

Soil degradation, including decreased fertility and increased erosion, is a major concern in global agriculture, and particularly

in subtropical and tropical areas (Jianping, 1999). Intensive, long-term cultivation of these highly weathered soils often results in their degradation, which includes soil acidification, soil organic matter (SOM) depletion and severe soil erosion (De Meyer et al., 2011 and Hoyos, 2005). The decrease in soil organic carbon (SOC) caused by long-term cultivation decreases the aggregate stability of the soil and increases its erosion potential (Annabi et al., 2011 and Tejada and Gonzalez, 2007). Therefore, the effective maintenance Epigenetics inhibitor of SOM in degraded soils can help preserve soil fertility and reduce

erosion susceptibility by promoting soil aggregation stability, and improving hydraulic conductivity and water retention ability (Auerswald et al., 2003 and Tejada and Gonzalez, 2007). Biochar is a carbon-rich product produced by the slow thermo-chemical pyrolysis of biomass materials. Organic wastes, such as livestock manures, sewage sludge, crop residues and composts are converted to biochars and then applied to soils as an amendment. In the past, organic amendments and polymers such as polyacrylamides (PAM) were used to improve soil physicochemical properties and protect soils from erosion (Busscher et al., 2011). However, the depletion of soil organic matter and the high cost of BLU9931 in vivo PAM application are serious problems to overcome. Many studies have shown that biochar is a useful resource to improve the physicochemical properties of soil, effectively maintain SOM levels, increase fertilizer-use efficiency and increase crop production, particularly for long-term cultivated soils in subtropical and tropical regions

(Chan et al., 2007, Chan et al., 2008, Deenik et al., 2011 and Van Zwieten et al., 2010). Furthermore, the application of biochar to soils might be a practical method to aid in the long-term maintenance of the soil organic carbon contents and soil fertility. The application of biochar to soils can maintain SOM levels and soil aggregation stability (Kimetu and Lehmann, 2010, Tejada and Gonzalez, 2007 and Trompowsky et al., 2005) because biochar is characterized by recalcitrant Montelukast Sodium C from microbial degradation and by a charged surface with organic functional groups. Reducing soil erosion potential, maintaining SOM, and improving soil aggregative stability are critical processes. Previous studies have demonstrated the importance of SOM to the physiochemical properties of soil (Materechera, 2009 and Wuddivira et al., 2009) and erosion susceptibility (Auerswald et al., 2003 and Tejada and Gonzalez, 2007). Many studies have reported the use of biochar as an amendment for crop production, and improving the chemical properties in highly weathered tropical soils (Iswaran et al., 1980 and Liang et al., 2006).

Maries strain were represented by the design and synthesis of 30-

Maries strain were represented by the design and synthesis of 30-mer, overlapping peptides (Fig. 1) [5] and [6].

Sera from all animals obtained prior to immunization, 42 days after the last immunization, and 45 days after challenge with live organisms were tested. Enzyme-linked immunosorbent assays (ELISA) were done to map the anti-Msp2 antibody response. Immulon-II 96-well plates were coated with 1 μg of peptide per well in coating buffer (50 mM Na2CO3, pH 9.6) overnight at 4 °C, washed with PBS containing 0.05% (vol/vol) Tween20, and then blocked with Olaparib in vitro PBS containing 5% (wt/vol) milk and 0.05% (vol/vol) Tween20 for 1 h. To determine the end-point titers, sera were diluted starting at 1:10 in blocking buffer. Dilutions buy LBH589 were doubled until a signal was no longer detected or a dilution of 1:20,480 was reached. Titers were reported as the reciprocal of the last dilution in which

antibody binding was detected. Fifty μl of each diluted serum sample were added to each well in triplicate. Following washing, 50 μl of 1:500 dilution of recombinant protein G-horseradish peroxidase (Zymed, Carlsbad, CA), to detect IgG binding, were added per well, and the plates incubated for 1 h at room temperature. After additional washes, binding of protein G to IgG was detected using Sureblue microwell peroxidase substrate (Kirkegaard and Perry Laboratories, Gaithersburg, MD) at 100 μl/well for 15 min. and stopped with 100 μl of 1% hydrochloric acid. The optical density at 450 nm was determined. Positive binding was statistically defined as exceeding the mean plus 2 standard deviations of the OD450 of preimmune serum from the same animal for the specific peptide, exceeding 2 times the absolute mean value of OD450 of the test serum with negative control peptide P1, and greater than the mean plus 2 standard deviations of the OD450 for a specific peptide from all control animals that received only adjuvant. To evaluate and compare the number of Msp2 epitopes recognized, breadth scores and mean titers were determined for each serum sample. To establish a

breadth score, one point was given for each peptide recognized at a serum dilution of ≥1:10. All of the points for each conserved region peptide and all of the points for each HVR peptide were summed separately. In the order to compare 17-DMAG (Alvespimycin) HCl the breadth scores between the CR and HVR peptides, the breadth score was divided by the number of peptides in each group. For example, animal 5933 had antibody recognizing 6 of the 15 CR peptides and 14 of the 18 HVR peptides, giving a CR breadth score of 0.40 and a HVR breadth score of 0.78 (Table 3). To establish a mean titer for a serum sample, the reciprocal of the end-point dilution for each peptide was summed and divided by the number of peptides recognized by that particular serum sample. The titer scores to the CR and HVR region peptides were determined separately.

All participants were reviewed fortnightly by an unblinded therap

All participants were reviewed fortnightly by an unblinded therapist, who contacted them either by phone or in person to monitor and record adherence to their programs. The splint intervention was ceased following assessments at 8 weeks, and all participants continued with the

exercises and advice unsupervised until 12 weeks. Outcomes were measured immediately before randomisation (ie, baseline) and then at 8 weeks, with a follow-up measure at 12 weeks after randomisation. A blinded assessor performed assessments at 8 weeks, at least 12 hours after the splint was last worn; an assessor not blinded to group allocation performed assessments at 12 weeks. The success of blinding at 8 weeks was examined using an assessor questionnaire administered at the completion of each participant’s assessment. Eight Crizotinib chemical structure outcome measures were used. The two primary outcome measures reflected impairment and participation restriction, namely: passive wrist extension, and the Patient Rated Hand Wrist

Evaluation (PRHWE). Secondary outcome measures were active wrist extension, flexion, radial and ulnar deviation, and the performance and satisfaction items of the Canadian Occupational Performance Measure (COPM). The details of each follow. Passive wrist extension: Passive wrist extension was measured with the application of a standardised torque using a device specifically designed for this purpose ( Figure 2). The device consisted of a wheel mounted on the selleck chemicals llc side of an arm board that was hinged to a mobile plate. With the device on a horizontal surface, the hand was strapped to the mobile plate rotating

about the axis of the wrist with the forearm pronated. The fingers were allowed to lie over the distal end of the plate to prevent finger flexor tightness confounding the measurement. The wheel acted to ensure the moment arm remained constant (9 cm) regardless of wrist angle. 250 g weights were serially added with 30 seconds of pre-stretch until a final weight of 1.25 kg was reached, corresponding to 0.22 Nm increments in torque with a final torque of 1.10 Nm. Passive wrist extension was measured as the angle between the mobile plate and Rebamipide a vertical drop-line 30 seconds after the application of the final torque. The reliability of the device was evaluated before the commencement of the trial by having two assessors measure the passive wrist extension of 11 people with contracture following fracture. An ICC of 0.98 (95% CI, 0.96 to 0.99) was established. A between-group difference of 10 deg was deemed sufficiently important to justify the expense and inconvenience of the splinting regimen. Patient Rated Hand and Wrist Evaluation(PRHWE): The PRHWE ( MacDermid and Tottenham 2004) is a 15-item questionnaire designed to reflect the implications of upper limb injuries on activities of daily living.

Startle responses can be measured in rodents using loud acoustic

Startle responses can be measured in rodents using loud acoustic tones, and can be enhanced in fear-potentiated startle, a paradigm in which startle is tested in an environment previously paired with footshocks. selleck compound Central administration of NPY inhibits both basal acoustic startle and fear-potentiated startle in rodents (Broqua and et al, 1995, Gilpin and et al, 2011 and Gutman and et al, 2008). Another study demonstrated that NPY infusion into the basolateral, but not central nucleus, of the amygdala mimics the effects of NPY on acoustic startle and fear-potentiated responses (Gutman

et al., 2008). Central administration of a Y1R agonist attenuates fear-potentiated startle, whereas a Y2R agonist was reported to have no effect (Broqua et al., 1995). In genetically Selleck OSI-906 modified rodents, knockout of NPY or Y2R enhances acoustic startle (Bannon et al., 2000), whereas deletion of the Y1R yields impaired habituation of startle responses (Karl et al., 2010). These studies indicate a role for NPY in the modulation of startle and potential for NPY as a therapeutic for hyperarousal in stress-related psychiatric

disorders. However the receptor subtypes and brain regions dictating NPY-induced resilience to this behavioral response remain unclear. The NE system originating in the locus coeruleus (LC) is a brainstem region contributing to arousal responses (Samuels and Szabadi, 2008 and Sara and Bouret, 2012), thus NPY may mediate arousal behavior by directly acting in the LC or by influencing brain regions upstream. Fig. 1 demonstrates putative neurochemical interactions and circuitry that may influence the function of the LC-NE system and arousal behavior. NPY inhibits the firing rate of NE neurons in the LC, and potentiates the effect of NE on presynaptic autoinhibition

of neuronal firing (Illes et al., 1993 and Finta et al., 1992). This electrophysiological evidence suggests that NPY may act to restrain the activity of noradrenergic neurons, which may have important implications for stress-psychiatric diseases in which the LC-NE system is disrupted. In combination with anatomical evidence demonstrating rich NPY (-)-p-Bromotetramisole Oxalate innervation of the LC (Smialowska, 1988) (shown in Fig. 2),these studies suggest that NPY may play an important role in the regulation of noradrenergic stress responses and arousal via NE circuitry. Recent rodent studies suggest that NPY may be useful in the treatment of psychiatric diseases such as PTSD, which is heavily characterized by behavioral sequelae associated with fear. NPY has been found to influence multiple fear-related behaviors including the acquisition, incubation, expression, and extinction of conditioned fear. For example, i.c.v.

Eight-week-old female BALB/c mice (5 per group) were vaccinated w

Eight-week-old female BALB/c mice (5 per group) were vaccinated with either Qβ-Eot or Qβ-IL-5, or the combination of both without the addition of adjuvant. 50 μg of total protein of each vaccine was Compound Library injected subcutaneously on days 0, 21 and 35. Mice were subjected to retro-orbital bleeding on days 0, 21, 35 and

45 and sera analyzed by the use of IL-5 and eotaxin-specific ELISA. ELISA plates were coated with mouse rIL-5 or r-eotaxin at a concentration of 5 μg/ml. Plates were blocked then incubated with serially diluted mouse sera. Bound antibodies were detected with enzymatically labeled anti-mouse IgG antibody. As a control, preimmune serum from the same mice was tested. Antibody titers were calculated as the serum dilution which led to a half-maximal of OD450 (OD50%). To induce allergic airway inflammation, female BALB/c mice (5 per group) were injected (i.p.) with 10 μg of OVA (Grade V, Sigma–Aldrich) mixed with 2 mg of alum (Aluminium Hydroxide

Gel Adjuvant, Brenntag Biosector, Denmark). 10 days later, mice were challenged daily with 100 μg of OVA by intranasal administration for 4 days. 24 hours after the last challenge, BAL and lungs were subjected to histology. Mice injected i.p. with OVA NVP-BKM120 molecular weight and alum but not challenged intranasaly with OVA served as a negative control for disease induction in these experiments. To assay the activity of r-eotaxin, BALB/c mice (5 per group) were immunized i.p. on days 0 and 3 with 100 μg of OVA mixed with 2 mg

of alum. On day 14, mice were injected with either PBS or 0.5 μg of r-eotaxin i.v. Thirty min after injection, blood samples were collected from each mouse and blood smears were made. The slides were dried in air and stained with Kit RAL 555 (Réactifs RAL) according to manufacture’s protocol (a fast-acting variation of May-Grünwald Giemsa staining). The percentage of Cediranib (AZD2171) eosinophils was evaluated with a light microscope. In the model of allergic airway inflammation, bronchoalveolar cells were collected in successive lavages (BAL) using 0.5 ml aliquots of PBS with 2% BSA at room temperature until the total volume reaches 1.2 ml. The total number of cells in the BAL was counted with a Coulter Counter (Beckman Coulter, Inc.). Cytospins were performed with Shandon Cytospin apparatus (Thermo Fisher Scientific, Inc.) and stained with Kit RAL 555 (Réactifs RAL) according to the manufacture’s protocol. Differential cell counts were performed with at least 200 leukocytes. Mouse lungs were removed and fixed in 10% PBS buffered formalin. Paraffin sections were stained with Chromotrope 2R to identify eosinophils [29]. For statistical analysis, Student’s t-test was used. p-Values <0.05 were considered significant. Recombinant murine IL-5 with an N-terminal hexa-histidine tag, an enterokinase cleavage site and a linker containing a cysteine residue was expressed and purified.

Our results also show that switching from Tritanrix HB + Hib to Q

Our results also show that switching from Tritanrix HB + Hib to Quinvaxem had no negative impact with regards to safety; AE patterns were comparable find more between the groups and well in line with those observed

in earlier studies with Quinvaxem [3]. The current study was conducted to provide data on the interchangeability of wP pentavalent vaccines in a primary vaccination course. Until now, only the interchangeability of wP pentavalent vaccines as a booster has been studied [13]. Substituting a booster dose of a lyophilized pentavalent vaccine with that of a fully liquid one was shown to be highly immunogenic with a favorable safety profile. It is, however, clear that there is limited interchangeability data available. The interchangeability

of the individual components of pentavalent vaccines, as well as for aP-containing vaccines has been shown [11], [12], [19], [20], [21], [22], [23] and [24]. Although data for aP containing vaccines is limited, their interchangeability is supported by the Advisory Committee on Immunization Practices (ACIP) in the USA [25] and the Public Health Agency of Canada (PHAC) [26]. The recommendations given by ACIP and the PHAC were put in place because both the USA and Canada use pentavalent vaccines Protease Inhibitor Library price from more than one manufacturer, and it is possible that different products may be used in one individual during a vaccination course as a result, for example, of migration or vaccine shortages. It has also been shown that in a vaccine shortage situation 25% of children whose vaccination was deferred did not return for the indicated vaccine [26], leaving a population of children partially vaccinated and susceptible to disease. A reason for

the limited published data may be attributable to the fact that interchangeability is particularly difficult to study. If we consider that there are six WHO pre-qualified Parvulin pentavalent vaccines, and three doses in a primary vaccine course, then there are 125 theoretically possible permutations of vaccine doses. The chances of any particular permutation having been studied are very low. As stated by Decker [10]: “once we are faced with multiple combination vaccines, the likelihood shrinks that any particular substitution will have been studied explicitly”. We studied only one of 8 possible permutations using the two vaccines, and it is unrealistic to assume that all 8 should be tested and more so that all 125 be tested. Halsey, in his 1995 paper entitled: “Practical considerations regarding the impact on immunization schedules of the introduction of new combined vaccines”, discussed the inherent problems related to the increasing number of combined childhood vaccines available and in turn, the increasing number of potential permutations. The evaluation of all potential permutations has to be balanced against the cost of running clinical trials.

A summary of some of the practical difficulties that arise in usi

A summary of some of the practical difficulties that arise in using NSP ELISA to help substantiate FMD freedom is provided in Supplementary Table 4. Three workshops in 2007 examined the design and interpretation of post FMD-vaccination serosurveillance by NSP tests [52]. Their aim was to test the feasibility and consequences of applying the above-described rules after applying emergency

vaccination in three plausible scenarios involving different outbreak sizes, affected species and livestock densities. The summary recommendations of the workshops are provided in Supplementary Table 5 and the following key issues are further discussed below: (1) the requirement to sample all vaccinated SB203580 animals; (2) the follow-up investigation required to establish the significance of seroreactors identified;

(3) the criteria for removal of seropositive animals and herds; (4) what can be done with such animals (slaughter for consumption or destruction); (5) the impact of finding seroreactors during the process of surveillance with the RG7204 datasheet objective of regaining the status “FMD free where vaccination is not practised”. Even with tests of suboptimal sensitivity (70–90%), a low prevalence of infection can be detected with high confidence in large groups of animals without sampling and testing every animal. However, in large herds, the animals are often segregated in smaller groups that may be considered as separate epidemiological

units and in this case, the number of animals per epidemiological unit would be the denominator for calculation of sample sizes. For NSP serosurveillance, using a test with Sp = 0.995 and Se = 0.7, then detection of seroconversion at 95% confidence, at a prevalence of 2%, in an epidemiological unit of 1000 animals, would require 513 animals to be sampled and the cut-point would be five (i.e. finding five or fewer reactors could still be consistent with absence of true seroconversion, i.e. probability of 2% or more seropositive animals is less than 5%). If it were accepted that only strongly seroconverting animals are likely to (have) spread infection, then the Se figure could be increased to 0.9, in which case 366 samples would need to be tested and the cut-point would become four (FreeCalc; [53]). Reduction STK38 of the numbers sampled in large herds is often relevant for pigs which also do not have risks associated with the development of FMDV carriers. Clinical disease is also rather obvious in pigs so that NSP surveys add less value. Therefore, surveillance in pigs should be targeted towards the identification of disease and virus circulation. Studies on vaccinated pig herds in Hong Kong suggested an all-or-nothing effect, with widespread clinical disease and NSP seroconversion (49–82% seroprevalence) or neither clinical disease nor seroconversion [54].